93/12 (Pantoprazole sodium delayed-release 40 mg)
Pill imprint 93/12 has been identified as Pantoprazole sodium delayed-release 40 mg.
Pantoprazole is used in the treatment of gerd; barrett's esophagus; zollinger-ellison syndrome; helicobacter pylori infection; erosive esophagitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 93/12 (Pantoprazole sodium delayed-release 40 mg)
- 40 mg
- 10.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium carbonate
D&C Yellow No. 10
FD&C Yellow No. 6
hypromellose 2910 (15 mPa.s)
ferric oxide yellow
low substituted hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol 4000
|NDC Code||Manufacturer / Repackager|
|18837-0296||Innoviant Pharmacy Inc (repackager)|
|54868-5846||Physicians Total Care Inc (repackager)|
|68071-0782||Nucare Pharmaceuticals Inc (repackager)|
|66336-0405||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about pantoprazole
- Pantoprazole delayed-release tablets
- Pantoprazole suspension
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...